期刊文献+

血液样本加热灭活对液相色谱-质谱联用法监测丙戊酸血药浓度的影响 被引量:2

Effects of the heat-inactivation of blood samples on blood concentration monitoring of valproic acid by LC-MS
原文传递
导出
摘要 目的:探讨血液样本56℃灭活30 min对液相色谱-质谱联用(LC-MS)法丙戊酸(valproic acid, VPA)治疗药物监测的影响。方法:血浆样本经乙腈蛋白沉淀处理后,采用LC-MS法测定血浆质控品和临床样本灭活前后VPA的浓度。采用Bland-Ahman、Passing-Bablok回归和线性回归分析灭活前、后测定结果的一致性和相关性。结果:VPA 56℃灭活30 min未有明显降解,灭活前后基质效应无明显差异。128例临床样本中,灭活组血药浓度(四分位数)为82.5(64.6~102.4)μg·mL^(-1),未灭活组血药浓度为83.0(62.4~99.3)μg·mL^(-1),灭活前后VPA血药浓度差异无统计学意义(P>0.05)。经Bland-Altman分析,95%CI=(0.405,2.408),95.4%(6/128)的差值都位于一致性界限内,提示灭活前后测定值一致性良好。Passing–Bablok回归方程为VPA_(灭活)=1.016×VPA_(非灭活)-0.017 2,截距95%CI=(-2.254,2.183),斜率95%CI=(0.979,1.050)。Spearman相关系数为0.986 1(P<0.01),表明灭活前、后VPA血浆浓度值具有良好的相关性。结论:56℃30 min灭活结合蛋白沉淀处理血浆样本对LC-MS法测定VPA血浆浓度无明显影响,可用于VPA常规治疗药物监测。 OBJECTIVE To investigate the effects of inactivation at 56 ℃ for 30 min on therapeutic drug monitoring(TDM) of valproic acid(VPA) by LC-MS.METHODS After protein precipitation by acetonitrile, inactivated and non-inactivated VPA concentrations in quality control and clinical samples were quantified by LC-MS. Furthermore, the difference, consistency and correlation of the results were evaluated and analyzed by Bland-Altman, Passing-Bablok regression and linear regression.RESULTS There was no significant degradation of VPA after inactivation at 56 ℃ for 30 min, and the matrix effect had no significant difference when compared with non-inactivated VPA concentration. In 128 cases of clinical samples, the VPA blood concentrations of the inactivated and non-inactivated groups were 82.5(64.6-102.4) μg·mL^(-1) and 83.0(62.4-99.3) μg·mL^(-1), respectively, which were not statistically significant(P>0.05). Bland-Altman analysis showed that the consistency between the measurements of inactivated and non-inactivated samples was good with 95.4%(6/128)of the difference values within the limits of agreement with 95% CI=(0.405, 2.408). The Passing–Bablok regression equation between the inactivated and noninactivated VPA concentrations was VPA_(inactivated)=1.016×VPA_(noninactivated)-0.017 2, which was with 95% CI=(-2.254, 2.183) for the intercept and(0.979, 1.050) for the slope. The Pearson correlation coefficient was 0.9861 with P<0.01, indicating that the VPA plasma concentration values had a good correlation before and after inactivation.CONCLUSION The plasma sample treated with inactivation at 56℃ for 30 min coupled with protein precipitation has little effect on the determination of plasma concentration of VPA by LC-MS, which can be used for the routine TDM of VPA.
作者 丁靖 张燕 杨柳 李亚娟 蒙卓成 郑璇 DING Jing;ZHANG Yan;YANG Liu;LI Ya-juan;MENG Zhuo-cheng;ZHENG Xuan(Xi'an Mental Health Center,Shaanxi Xi'an 710100,China;Xi'an Key Laboratory o£Pharmaceutical(Mental Health),Shaanxi Xi'an 710100,China)
出处 《中国医院药学杂志》 CAS 北大核心 2022年第5期534-537,共4页 Chinese Journal of Hospital Pharmacy
基金 科技创新平台建设/重点实验室建设项目(编号:201805051ZD2CG35) 陕西省卫生健康科研基金项目(编号:2021D003) 西安市科协青年人才托举计划(编号:095920211312)。
关键词 丙戊酸 液相色谱-质谱联用法 灭活 治疗药物监测 一致性 相关性 valproic acid LC-MS inactivation therapeutic drug monitoring consistency correlation
  • 相关文献

参考文献9

二级参考文献34

  • 1李建新,刘小平,肖平.临床实验室获得性感染[J].中华检验医学杂志,2006,29(11):1050-1052. 被引量:15
  • 2Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med, 2005, 11(7) : 791-796.
  • 3Lindenbach BD, Evans MJ, Syder AJ, et al. Complete replication of hepatitis C virus in cell culture. Science, 2005, 309 ( 5734 ) : 623 -626.
  • 4Zhong J, Gastaminza P, Cheng G, et al. Robust hepatitis C virus infection in vitro. Proc Natl Aead Sei USA, 2005, 102 (26): 9294 -9299.
  • 5Akazawa D, Date T, Morikawa K, et al. CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection. J Virol, 2007, 81 (10) : 5036-5045.
  • 6Yi M, Ma Y, Yates J, et al. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J Virol, 2007, 81 (2) : 629-638.
  • 7Muller-Breitkreutz K, Mohr H. Hepatitis C and human immunodeficiency virus RNA degradation by methylene blue/light treatment of human plasma. J Med Virol, 1998, 56(3) : 239-245.
  • 8Darnell ME, Subbarao K, Feinstone SM, et al. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARSCoV. J Virol Methods, 2004, 121(1) : 85-91.
  • 9Schlegel A, Immelmarm A, Kempf C. Virus inactivation of plasma-derived proteins by pasteurization in the presence of guanidine hydrochloride. Transfusion, 2001,41 ( 3 ) : 382-389.
  • 10Robertson S. Module 8 : Yellow fever. In the immunological basis for immunization. WHO, Global Programme for Vaccines and Immunization, Geneva. 1993.

共引文献51

同被引文献14

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部